BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8056889)

  • 1. Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
    Spencer DM; Bigler LR; Wilkin JK; Gams RA
    J Dermatol Surg Oncol; 1994 Aug; 20(8):544-7. PubMed ID: 8056889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
    Lai CH; Hsueh S; Chao AS; Soong YK
    Br J Obstet Gynaecol; 1994 Jun; 101(6):547-9. PubMed ID: 8018650
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of brain metastases from breast cancer to megestrol acetate: a case report.
    Stewart DJ; Dahrouge S
    J Neurooncol; 1995; 24(3):299-301. PubMed ID: 7595761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
    Lim MC; Lee S; Seo SS
    Onkologie; 2010; 33(5):260-2. PubMed ID: 20502061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
    Pautier P; Vergote I; Joly F; Melichar B; Kutarska E; Hall G; Lisyanskaya A; Reed N; Oaknin A; Ostapenko V; Zvirbule Z; Chetaille E; Geniaux A; Shoaib M; Green JA
    Int J Gynecol Cancer; 2017 Feb; 27(2):258-266. PubMed ID: 27870712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
    Geisler HE
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glassy cell carcinoma of the endometrium responsive to megestrol acetate.
    Dawson EC; Belinson JL; Lee K
    Gynecol Oncol; 1989 Apr; 33(1):121-4. PubMed ID: 2703161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
    Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal therapy of gynecologic cancers.
    Durant JR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
    Cruz JM; Muss HB; Russell G
    Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.
    Eftekhar Z; Izadi-Mood N; Yarandi F; Shojaei H; Rezaei Z; Mohagheghi S
    Int J Gynecol Cancer; 2009 Feb; 19(2):249-52. PubMed ID: 19396003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical castration using megestrol acetate and minidose estrogen.
    Johnson DE; Babaian RJ; Swanson DA; von Eschenbach AC; Wishnow KI; Tenney D
    Urology; 1988 May; 31(5):371-4. PubMed ID: 3284149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
    Wang CB; Wang CJ; Huang HJ; Hsueh S; Chou HH; Soong YK; Lai CH
    Cancer; 2002 Apr; 94(8):2192-8. PubMed ID: 12001117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
    Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
    Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Cornelison TL; Baker TR; Piver MS; Driscoll DL
    Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.